TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease

References

• Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124(6):1–14. doi: 10.1172/JCI72271.
   Web of Science ®Google Scholar
• Jha JC, Banal C, Chow BS, et al. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal. 2016;25(12):657–684. doi: 10.1089/ars.2016.6664.
   PubMed Web of Science ®Google Scholar
• Ren H, Shao Y, Wu C, et al. VASH-1 regulates oxidative stress and fibrosis in diabetic kidney disease via SIRT1/HIF1α and TGFβ1/Smad3 signaling pathways. Front Mol Biosci. 2020;7:137. doi: 10.3389/fmolb.2020.00137.
   PubMed Web of Science ®Google Scholar
• Sedeek M, Nasrallah R, Touyz RM, et al. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol. 2013;24(10):1512–1518. doi: 10.1681/ASN.2012111112.
   PubMed Web of Science ®Google Scholar
• Schulze PC, Yoshioka J, Takahashi T, et al. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem. 2004;279(29):30369–30374. doi: 10.1074/jbc.M400549200.
   PubMed Web of Science ®Google Scholar
• Advani A, Gilbert RE, Thai K, et al. Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol. 2009;20(4):730–741. doi: 10.1681/ASN.2008020142.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Uehara S, Ikeda T, et al. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int. 2003;64(5):1632–1642. doi: 10.1046/j.1523-1755.2003.00263.x.
   PubMed Web of Science ®Google Scholar
• Shah A, Xia L, Masson EA, et al. Thioredoxin-interacting protein deficiency protects against diabetic nephropathy. J Am Soc Nephrol. 2015;26(12):2963–2977. doi: 10.1681/ASN.2014050528.
   PubMed Web of Science ®Google Scholar
• Wei J, Shi Y, Hou Y, et al. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells. Cell Signal. 2013;25(12):2788–2796. doi: 10.1016/j.cellsig.2013.09.009.
   PubMed Web of Science ®Google Scholar
• Tan CY, Weier Q, Zhang Y, et al. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy. Nephron. 2015;129(2):109–127. doi: 10.1159/000368238.
   PubMed Web of Science ®Google Scholar
• Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460–473. doi: 10.1089/ars.2013.5371.
   PubMed Web of Science ®Google Scholar
• Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol. 2015;224(1):R15–30. doi: 10.1530/JOE-14-0437.
   PubMed Web of Science ®Google Scholar
• Huang C, Lin MZ, Cheng D, et al. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Lab Invest. 2014;94(3):309–320. doi: 10.1038/labinvest.2014.2.
   PubMed Web of Science ®Google Scholar
• Huang C, Zhang Y, Kelly DJ, et al. Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway. Sci Rep. 2016;6(1):29196. doi: 10.1038/srep29196.
   PubMedGoogle Scholar
• Sardiello M, Palmieri M, di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325(5939):473–477. doi: 10.1126/science.1174447.
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429–1433. doi: 10.1126/science.1204592.
   PubMed Web of Science ®Google Scholar
• Brijmohan AS, Batchu SN, Majumder S, et al. HDAC6 inhibition promotes transcription factor EB activation and is protective in experimental kidney disease. Front Pharmacol. 2018;9:34. doi: 10.3389/fphar.2018.00034.
   PubMed Web of Science ®Google Scholar
• Wang S, Jing K, Wu H, et al. Activation of transcription factor EB alleviates tubular epithelial cell injury via restoring lysosomal homeostasis in diabetic nephropathy. Oxid Med Cell Longev. 2022;2022:2812493. doi: 10.1155/2022/2812493.
   PubMed Web of Science ®Google Scholar
• Martina JA, Chen Y, Gucek M, et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8(6):903–914. doi: 10.4161/auto.19653.
   PubMed Web of Science ®Google Scholar
• Vega-Rubin-de-Celis S, Peña-Llopis S, Konda M, et al. Multistep regulation of TFEB by MTORC1. Autophagy. 2017;13(3):464–472. doi: 10.1080/15548627.2016.1271514.
   PubMed Web of Science ®Google Scholar
• Song S, Qiu D, Shi Y, et al. Thioredoxin-interacting protein deficiency alleviates phenotypic alterations of podocytes via inhibition of mTOR activation in diabetic nephropathy. J Cell Physiol. 2019;234(9):16485–16502. doi: 10.1002/jcp.28317.
   PubMed Web of Science ®Google Scholar
• Du C, Wu M, Liu H, et al. Thioredoxin-interacting protein regulates lipid metabolism via akt/mTOR pathway in diabetic kidney disease. Int J Biochem Cell Biol. 2016;79:1–13. doi: 10.1016/j.biocel.2016.08.006.
   PubMed Web of Science ®Google Scholar
• Zhao HJ, Wang S, Cheng H, et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol. 2006;17(10):2664–2669. doi: 10.1681/ASN.2006070798.
   PubMed Web of Science ®Google Scholar
• Eskelinen E-L. Fine structure of the autophagosome. Methods Mol Biol. 2008;445:11–28. doi: 10.1007/978-1-59745-157-4_2.
   PubMedGoogle Scholar
• Yasuda-Yamahara M, Kume S, Maegawa H. Role of mTOR in diabetic kidney disease. Antioxidants (Basel). 2021;10(2):321. doi: 10.3390/antiox10020321.
   PubMedGoogle Scholar
• Zhang W, Li X, Wang S, et al. Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases. Cell Death Discov. 2020;6(1):32. doi: 10.1038/s41420-020-0265-4.
   PubMed Web of Science ®Google Scholar
• Badid C, Desmouliere A, Babici D, et al. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol Dial Transplant. 2002;17(11):1993–1998. doi: 10.1093/ndt/17.11.1993.
   PubMed Web of Science ®Google Scholar
• Carew RM, Wang B, Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res. 2012;347(1):103–116. doi: 10.1007/s00441-011-1227-1.
   PubMed Web of Science ®Google Scholar
• Li Z, Yao Q, Tian Y, et al. Trehalose protects against cisplatin-induced cochlear hair cell damage by activating TFEB-mediated autophagy. Biochem Pharmacol. 2022;197:114904. doi: 10.1016/j.bcp.2021.114904.
   PubMed Web of Science ®Google Scholar
• Song JX, Sun YR, Peluso I, et al. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 2016;12(8):1372–1389. doi: 10.1080/15548627.2016.1179404.
   PubMed Web of Science ®Google Scholar
• Jha JC, Dai A, Garzarella J, et al. Independent of renox, NOX5 promotes renal inflammation and fibrosis in diabetes by activating ROS-sensitive pathways. Diabetes. 2022;71(6):1282–1298. doi: 10.2337/db21-1079.
   PubMed Web of Science ®Google Scholar
• Ji L, Wang Q, Huang F, et al. FOXO1 overexpression attenuates tubulointerstitial fibrosis and apoptosis in diabetic kidneys by ameliorating oxidative injury via TXNIP-TRX. Oxid Med Cell Longev. 2019;2019:3286928. doi: 10.1155/2019/3286928.
   PubMed Web of Science ®Google Scholar
• Song S, Qiu D, Wang Y, et al. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy. Exp Cell Res. 2020;388(2):111862. doi: 10.1016/j.yexcr.2020.111862.
   PubMed Web of Science ®Google Scholar
• Kim SI, Na HJ, Ding Y, et al. Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-β1. J Biol Chem. 2012;287(15):11677–11688. doi: 10.1074/jbc.M111.308460.
   PubMed Web of Science ®Google Scholar
• Kim WY, Nam SA, Song HC, et al. The role of autophagy in unilateral ureteral obstruction rat model. Nephrology (Carlton). 2012;17(2):148–159. doi: 10.1111/j.1440-1797.2011.01541.x.
   PubMed Web of Science ®Google Scholar
• Ma Z, Li L, Livingston MJ, et al. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. J Clin Invest. 2020;130(9):5011–5026. doi: 10.1172/JCI135536.
   PubMed Web of Science ®Google Scholar
• Han YC, Tang SQ, Liu YT, et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 2021;12(10):925. doi: 10.1038/s41419-021-04184-8.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Kim YA, Park KK. Anti-fibrotic effect of synthetic noncoding decoy ODNs for TFEB in an animal model of chronic kidney disease. Int J Mol Sci. 2022;23(15):8138. doi: 10.3390/ijms23158138.
   Web of Science ®Google Scholar
• Yang C, Chen XC, Li ZH, et al. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy. Autophagy. 2021;17(9):2325–2344. doi: 10.1080/15548627.2020.1824694.
   PubMed Web of Science ®Google Scholar
• Zhu L, Yuan Y, Yuan L, et al. Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Theranostics. 2020;10(13):5829–5844. doi: 10.7150/thno.44051.
   PubMed Web of Science ®Google Scholar
• Condon KJ, Sabatini DM. Nutrient regulation of mTORC1 at a glance. J Cell Sci. 2019;132(21):jcs222570. doi: 10.1242/jcs.222570.
   PubMed Web of Science ®Google Scholar
• Fantus D, Rogers NM, Grahammer F, et al. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat Rev Nephrol. 2016;12(10):587–609. doi: 10.1038/nrneph.2016.108.
   PubMed Web of Science ®Google Scholar
• Inoki K, Mori H, Wang J, et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121(6):2181–2196. doi: 10.1172/JCI44771.
   PubMed Web of Science ®Google Scholar
• Kogot-Levin A, Hinden L, Riahi Y, et al. Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors. Cell Rep. 2020;32(4):107954. doi: 10.1016/j.celrep.2020.107954.
   PubMed Web of Science ®Google Scholar
• Nakano T, Watanabe H, Imafuku T, et al. Indoxyl sulfate contributes to mTORC1-induced renal fibrosis via the OAT/NADPH oxidase/ROS pathway. Toxins (Basel). 2021;13(12):909. doi: 10.3390/toxins13120909.
   PubMed Web of Science ®Google Scholar
• Wang D, Kang L, Chen C, et al. Loss of legumain induces premature senescence and mediates aging-related renal fibrosis. Aging Cell. 2022;21(3):e13574. doi: 10.1111/acel.13574.
   PubMed Web of Science ®Google Scholar
• Luo C, Zhou S, Zhou Z, et al. Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells. J Am Soc Nephrol. 2018;29(4):1238–1256. doi: 10.1681/ASN.2017050574.
   PubMed Web of Science ®Google Scholar
• Cayo A, Venturini W, Rebolledo-Mira D, et al. Palbociclib-induced cellular senescence is modulated by the mTOR complex 1 and autophagy. Int J Mol Sci. 2023;24(11):9284. doi: 10.3390/ijms24119284.
   PubMed Web of Science ®Google Scholar
• Park HS, Song JW, Park JH, et al. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Autophagy. 2021;17(9):2549–2564. doi: 10.1080/15548627.2020.1834711.
   PubMed Web of Science ®Google Scholar
• Guo H, Bechtel-Walz W. The interplay of autophagy and oxidative stress in the kidney: what do we know? Nephron. 2023;147(10):627–642. doi: 10.1159/000531290.
   PubMed Web of Science ®Google Scholar